Short-term efficacy of rofecoxib and diclofenac in acute shoulder pain: A placebo-controlled randomized trial

PLoS Clinical Trials

Volumn 2, Issue 3, 2006, Pages

  Dougados, Maxime ^a,b   Le Henanff, Anne ^c,d   Logeart, Isabelle ^e   Ravaud, Philippe ^c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut Cochin   (France)

^c INSERM   (France)

^d BICHAT HOSPITAL   (France)

^e Dohme Chibret Centre de Recherche Riom   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; ROFECOXIB; STEROID;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; DYSPEPSIA; EAR DISEASE; FEMALE; FLATULENCE; GASTRITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; INFESTATION; INNER EAR DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; METHODOLOGY; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT SELECTION; PHYSICAL DISABILITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SHORT COURSE THERAPY; SHOULDER PAIN; SKIN DISEASE; SOFT TISSUE DISEASE; STATISTICAL SIGNIFICANCE; THORAX DISEASE; ULCER PERFORATION; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; VOMITING;

EID: 34249799609     PISSN: None     EISSN: 15555887     Source Type: Journal    
DOI: 10.1371/journal.pctr.0020009     Document Type: Article

References (35)

1. Rekola KE, Keinanen-Kiukaanniemi S, Takala J (1993) Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: Consultations with a physician. J Epidemiol Commun Health 47: 153-157.
2. Praemer A, Furner S, Rice D (1999) Musculoskeletal conditions in the United States. 2nd Ed. Rosemont (IL): American Academy of Orthopaedic Surgeons. 182 p.
3. Gomoll AH, Katz JN, Warner JPJ, Millett PJ (2004) Rotator cuff disorders recognition and management among patients with shoulder pain. Arthritis Rheum 12: 3751-3761.
4. Brox JI (2003) Shoulder pain. Best Pract Res Clin Rheumatol 17: 33-56.
5. Vidal L, Kneer W, Baturone M, Sigmund R (2001) Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder. Inflamm Res 50: S24-29.
6. Blair B, Rokito AS, Cuomo F, Jarolem K, Zukerman JD (1996) Efficacy of injections of corticosteroids for sub-acromial impingement syndrome. J Bone Joint Surg Am 78: 1685-1689.
7. Petri M, Dobrow R, Neiman R, Whiting-O'Keefe Q, Seaman WE (1987) Randomized, double-blind, placebo-controlled study of the treatment of the painful shoulder. Arthritis Rheum 30: 1040-1045.
8. Adebajo AO, Nash P, Hazleman BL (1990) A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol 17: 1207-1210.
9. Michener LA, Leggin BG (2001) A review of self-report scales for the assessment of functional limitation and disability of the shoulder. J Hand Ther 14: 68-76.
10. Dawson J, Hill G, Fitzpatrick R, Carr A (2001) The benefits of using patientbased methods of assessment. Medium-term results of an observational study of shoulder surgery. J Bone Joint Surg Br 83: 877-882.
11. Atroshi I, Gummesson C, Andersson B, Dahlgren E, Johansson A (2000) The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: Reliability and validity of the Swedish version evaluated in 176 patients. Acta Orthop Scand 71: 613-618.
12. Triffitt PD, Wildin C, Hajioff D (1999) The reproducibility of measurement of shoulder movement. Acta Orthop Scand 70: 322-324.
13. Petri M, Hufman SL, Waser G, Cui H, Snabes MC, et al. (2004) Celecoxib effectively treats patients with acute shoulder tendonitis/bursitis. J Rheumatol 31: 1614-1620.
14. Brox JI (2003) Shoulder pain. Best Practice Res Clin Rheumatol 17: 33-56.
15. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343: 1520-1528.
16. Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, et al. (2002) Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: A randomized, placebo-controlled clinical trial. Clin Ther 24: 490-503.
17. Morrison BW, Daniels SE, Kotey P, Cantu N, Seidenberg B (1999) Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: A randomized controlled trial. Obstet Gynecol 94: 504-508.
18. Reicin A, Brown J, Jove M, de Andrade JR, Bourne M, et al. (2001) Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain. Am J Orthop 30: 4048.
19. Jobe FW, Moynes DR (1982) Delineation of diagnostic criteria and a rehabilitation program for rotator cuff injuries. Am J Sports Med 10: 336-339.
20. Noel E, Walch G, Bochu H (1989) La manoeuvre de Jobe. Rev Rhum Mal Osteoart 56: 803-804.
21. Neer CS, Watson KC, Stanton FJ (1982) Recent experience in total shoulder replacement. J Bone Joint Surg 64A: 319-336.
22. Lecomte J, Buyse H, Taymans J, Montil T (1994) Treatment of tendinitis and bursitis: A comparison of nimesulide and naproxen sodium in a double-blind parallel trial. Eur J Rheumatol Inflam 14: 29-32.
23. van der Heijden GJ (1999) Shoulder disorders: A state-of-the-art review. Baillière's Best Pract Res Clin Rheumatol 13: 287-309.
24. Bot SDM, Terwee CB, van der Windt DAWM, Bouter LM, Dekker J, et al. (2004) Clinimetric evaluation of shoulder disability questionnaires: A systematic review of the literature. Ann Rheum Dis 63: 335-341.
25. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, et al. (2003) Outcomes from the patient perspective workshop at OMERACT 6. J Rheumatol 30: 868-872.
26. Huskisson EC (1974) Measurement of pain. Lancet 2: 143-148.
27. Bellamy N, Kirwan J, Altman R, Boers M, Brandt K, et al. (1997) Recommendations for core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis. Results of consensus development at OMERACT III. J Rheumatol 24: 799-802.
28. Wells G, Anderson J, Beaton D, Bellamy N, Boers M, et al. (2001) Minimal clinically important difference module: Summary, recommendation, and research agenda. J Rheumatol 28: 452-454.
29. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, et al. (2005) Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: The minimal clinically important improvement. Ann Rheum Dis 64: 29-33.
30. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, et al. (2005) Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 64: 34-37.
31. Dougados M (2005) It's good to feel better but it is better to feel good. J Rheumatol 32: 1-2.
32. Falgarone G, Zerkak D, Bauer C, Messow M, Dougados M (2005) How to define a minimal clinically individual state (MCIS) with pain VAS in daily practice for patients suffering from musculoskeletal disorders. Clin Exp Rheumatol 23: 235-238.
33. Green S, Buchbinder R, Glazier R, Forbes A (2006) Interventions for shoulder pain. In: The Cochrane Library, Issue 1. Chichester (UK) John Willey & Sons.
34. Speed C (01.02.2006) Shoulder pain: Oral drug treatment. Non-steroidal anti-inflammatory drugs (oral). BMJ Clin Evid. Available: http://www.clinicalevidence.com/ceweb/conditions/msd/1107/1107.jsp. Accessed: 6 February 2007.
35. Bertin P, Behier JM, Noel E, Leroux JL (2003) Celecoxib is as efficacious as naproxen in the management of acute shoulder pain. J Int Med Res 31: 102-112.